Drugs & Aging

, Volume 33, Issue 7, pp 461–473 | Cite as

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices

  • Federico Lavorini
  • Claudia Mannini
  • Elisa Chellini
  • Giovanni A. Fontana
Review Article

Abstract

Chronic obstructive pulmonary disease (COPD) is common in older people. Inhaled medications are the mainstay of pharmacological treatment of COPD, and are typically administered by handheld inhalers, such as pressurised metered-dose inhalers and dry powder inhalers, or by nebulisers. For each of the three major categories of aerosol delivery devices, several new inhalers have recently been launched, each with their own particularities, advantages and disadvantages. Consequently, broader availability of new drug–device combinations will increase prescription opportunities. Despite this, however, there is limited guidance available in published guidelines on the choice of inhalers, and still less consideration is given to elderly patients with COPD. The aim of this article is to provide a guide for healthcare professionals on device selection and factors to be considered for effective inhaled drug delivery in elderly COPD patients, including device factors (device type and complexity of use), patient factors (inspiratory capabilities, manual dexterity and hand strength, cognitive ability, co-morbidities) and considerations for healthcare professionals (proper education of patients in device use).

References

  1. 1.
    Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest. 2002;121(5 Suppl):121s–6s.CrossRefPubMedGoogle Scholar
  2. 2.
    Murray CJ. Lopez AD Alternative projections of mortality, disability by cause 1990–2020. Global Burden of Disease Study. Lancet. 1997;349:1498–504.CrossRefPubMedGoogle Scholar
  3. 3.
    Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. GOLD. http://www.goldcopd.org. Accessed 7 May 2016.
  4. 4.
    Pistolesi M, Camiciottoli G, Paoletti M, Marmai C, Lavorini F, Meoni E, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med. 2008;102:367–76.CrossRefPubMedGoogle Scholar
  5. 5.
    Dolovich MB, Ahrens RC, Hess DR, Anderson P, Dhand R, Rau JL, et al. American College of Chest Physicians; American College of Asthma, Allergy, and Immunology. Device selection and outcomes of aerosol therapy: evidence-based guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology. Chest. 2005;127:335–71.CrossRefPubMedGoogle Scholar
  6. 6.
    Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med. 2003;16:249–54.CrossRefPubMedGoogle Scholar
  7. 7.
    Crompton GK, Barnes PJ, Broeders M, Corrigan C, Corbetta L, Dekhuijzen R, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med. 2006;100:1479–94.CrossRefPubMedGoogle Scholar
  8. 8.
    Lavorini F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M, et al. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med. 2008;102:593–604.CrossRefPubMedGoogle Scholar
  9. 9.
    Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med Res. 2011;105:930–8.CrossRefGoogle Scholar
  10. 10.
    Akinbami LJ, Liu X. Chronic obstructive pulmonary disease among aged 18 and over in the United States, 1998-2009. NCHS Data Brief. 2011;63:1–8.PubMedGoogle Scholar
  11. 11.
    Janssens JP. Aging of the respiratory system: impact on pulmonary function tests sand adaptation to exertion. Clin Chest Med. 2005;26:469–72.CrossRefPubMedGoogle Scholar
  12. 12.
    Allen SC. Competence thresholds for the use of inhalers in people with dementia. Age Ageing. 1997;26:83–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Dalby R, Spallek M, Voshaar T. A review of the development of Respimat soft mist inhaler. Int J Pharm. 2004;283:1–9.CrossRefPubMedGoogle Scholar
  14. 14.
    Lavorini F, Fontana GA, Usmani OS. New inhaler devices—the good, the bad and the ugly. Respiration. 2014;88:3–15.CrossRefPubMedGoogle Scholar
  15. 15.
    Leach CL. The CFC to HFA transition and its impact on pulmonary drug development. Respir Care. 2005;50:1201–8.PubMedGoogle Scholar
  16. 16.
    Fink JB. Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000;45:623–35.PubMedGoogle Scholar
  17. 17.
    Hendeles L, Colice GL, Meyer RJ. Withdrawal of albuterol inhalers containing chlorofluorocarbon propellants. N Engl J Med. 2007;356:1344–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Acerbi D, Brambilla G, Kottakis I. Advances in asthma and COPD management: delivering CFC-free inhaled therapy using Modulite technology. Pulm Pharmacol Ther. 2007;20:290–303.CrossRefPubMedGoogle Scholar
  19. 19.
    Dhillon S, Keating GM. Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs. 2006;66:1475–83.CrossRefPubMedGoogle Scholar
  20. 20.
    Laube BL, Janssens HM, de Jongh FHC, Devadason SG, Dhand R, Diot P, et al. European Respiratory Society; International Society for Aerosols in Medicine. What the pulmonary specialist should know about the new inhalation therapies. Eur Respir J. 2011;37:1308–31.CrossRefPubMedGoogle Scholar
  21. 21.
    Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess. 2001;5:1–149.CrossRefPubMedGoogle Scholar
  22. 22.
    Lavorini F, Fontana GA. Targeting drugs to the lungs: effect of spacer device. Exp Opin Drug Deliv. 2009;6:91–102.CrossRefGoogle Scholar
  23. 23.
    Sadowski CA, Cor K, Cave A, Banh HL. Administration technique and acceptance of inhaler devices in patients with asthma and COPD. Ann Pharmacother. 2015;49:639–48.CrossRefPubMedGoogle Scholar
  24. 24.
    Newman SP, Weisz A, Talaee N, Clarke S. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax. 1991;46:712–6.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Price DB, Pearce L, Powell SR, Shirley J, Sayers MK. Handling and acceptability of the Easi-breathe device compared with a conventional metered dose inhaler by patients and practice nurses. Int J Clin Pract. 1999;53:31–6.PubMedGoogle Scholar
  26. 26.
    Hampson NB, Mueller MP. Reduction in patient timing errors using a breath-activated metered dose inhaler. Chest. 1994;106:462–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Lenny J, Innes J, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. Respir Med. 2000;94:496–500.CrossRefGoogle Scholar
  28. 28.
    Smith IJ, Bell J, Bowman N, Everard M, Stein S, Weers JG. Inhaler devices: what remains to be done? J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 2):s25–37.PubMedGoogle Scholar
  29. 29.
    Chrystyn H, Small M, Milligan G, Higgins V, Gil EG, Estruch J. Impact of patients’ satisfaction with their inhalers on treatment compliance and health status in COPD. Respir Med. 2014;108:358–65.CrossRefPubMedGoogle Scholar
  30. 30.
    Azouz W, Chrystyn H. Clarifying the dilemmas about inhalation techniques for dry powder inhalers: integrating science with clinical practice. Prim Care Respir J. 2012;21:208–13.CrossRefPubMedGoogle Scholar
  31. 31.
    de Boer AH, Gjaltema D, Hagedoorn P, Frijlink HW. Can ‘extrafine’ dry powder aerosols improve lung deposition? Eur J Pharm Biopharm. 2015;96:143–51.CrossRefPubMedGoogle Scholar
  32. 32.
    Pavkov R, Mueller S, Fiebich K, Singh D, Stowasser F, Pignatelli G. Characteristics of a capsule based dry powder inhaler for the delivery of indacaterol G. Curr Med Res Opin. 2010;26:2527–33.CrossRefPubMedGoogle Scholar
  33. 33.
    Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, et al. Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® dry powder inhalers. J Aerosol Med Pulm Drug Deliv. 2016;29:167–78.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir Med. 2012;6:91–101.CrossRefPubMedGoogle Scholar
  35. 35.
    Grant AC, Walker R, Hamilton M, Garrill K. The ELLIPTA® dry powder inhaler: design, functionality, in vitro dosing performance and critical task compliance by patients and caregivers. J Aerosol Med Pulm Drug Deliv. 2015;28:474–85.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Lavorini F, Levy ML, Corrigan C, Crompton G, ADMIT Working Group. The ADMIT series—issues in inhalation therapy. 6) Training tools for inhalation devices. Prim Care Respir Med. 2010;19:335–41.Google Scholar
  37. 37.
    Newman S. Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opin Drug Deliv. 2014;11:365–78.CrossRefPubMedGoogle Scholar
  38. 38.
    O’Callaghan C, Barry PW. The science of nebulized drug delivery. Thorax. 1997;52(suppl 2):s31–44.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Hess DR. Nebulizers: principles and performance. Respir Care. 2000;45:609–22.PubMedGoogle Scholar
  40. 40.
    Boe J, Dennis JH, O’Driscoll BR, Bauer TT, Carone M, Dautzenberg B, et al. European Respiratory Society guidelines on the use of nebulizers. Eur Respir J. 2001;18:228–42.CrossRefPubMedGoogle Scholar
  41. 41.
    Hess DR, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance. Effects of diluent volume, nebulizer flow, and nebulizer brand. Chest. 1996;110:498–505.CrossRefPubMedGoogle Scholar
  42. 42.
    Dhand R. Nebulisers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47:1406–16.PubMedGoogle Scholar
  43. 43.
    Nikander K. Adaptive aerosol delivery: the principles. Eur Respir Rev. 1999;7:385–7.CrossRefGoogle Scholar
  44. 44.
    Denyer J. Adaptive aerosol delivery in practice. Eur Respir Rev. 1997;7:388–9.Google Scholar
  45. 45.
    Waldrep JC, Dhand R. Advanced nebulizer designs employing vibrating mesh/aperture plate technologies for aerosol generation. Curr Drug Deliv. 2008;5:114–9.CrossRefPubMedGoogle Scholar
  46. 46.
    Skaria S, Smaldone GC. Omron NE U22: comparison between vibrating mesh and jet nebulizer. J Aerosol Med Pulm Drug Deliv. 2010;23:173–80.CrossRefPubMedGoogle Scholar
  47. 47.
    Geller DE. Comparing clinical features of nebulizer, metered-dose inhaler, and dry powder inhaler. Respir Care. 2005;50:1313–21.PubMedGoogle Scholar
  48. 48.
    Balzano G, Battiloro R, Biraghi M. Effectiveness and acceptability of domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. J Aerosol Med. 2000;13:25–33.CrossRefPubMedGoogle Scholar
  49. 49.
    Barta SK, Crawford A, Roberts CM. Survey of patients’ views of domiciliary nebuliser treatment for chronic lung disease. Respir Med. 2002;96:375–81.CrossRefPubMedGoogle Scholar
  50. 50.
    Dolovich MB, Dhand R. Aerosol drug delivery: developments in device design and clinical use. Lancet. 2011;377:1032–45.CrossRefPubMedGoogle Scholar
  51. 51.
    O’Donohue WJ, National Association for Medical Direction of Respiratory Care (NAMDRC) Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest. 1996;109:814–20.CrossRefPubMedGoogle Scholar
  52. 52.
    Kassner F, Hodder R, Bateman ED. A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat soft mist inhaler in patients with asthma and chronic obstructive pulmonary disease. Drugs. 2004;64:1671–82.CrossRefPubMedGoogle Scholar
  53. 53.
    Roche N, Reddel HK, Agusti A, Bateman ED, Krishnan JA, Martin RJ, et al. Respiratory Effectiveness Group. Integrating real-life studies in the global therapeutic research framework. Lancet. Respir Med. 2013;1:e29–30.Google Scholar
  54. 54.
    Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;20(11):CD000011.Google Scholar
  55. 55.
    Restrepo RD, Alvarez MT, Wittnebel LD, Sorenson H, Wettstein R, Vines DL, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:371–84.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Ingebrigtsen TS, Marott JL, Nordestgaard BG, Lange P, Hallas J, Dahl M, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30:51–9.CrossRefPubMedGoogle Scholar
  57. 57.
    Blaschke TF, Osterberg L, Vrijens B, Urquhart J. Adherence to medications: insights arising from studies on the unreliable link between prescribed and actual drug dosing histories. Annu Rev Pharmacol Toxicol. 2012;52:275–301.CrossRefPubMedGoogle Scholar
  58. 58.
    Vestbo J, Anderson JA, Calverley PM, Celli B, Ferguson GT, Jenkins C, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64:939–43.CrossRefPubMedGoogle Scholar
  59. 59.
    Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011;6:42.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Coventry PA, Fisher L, Kenning C, Bee P, Bower P. Capacity, responsibility, and motivation: a critical qualitative evaluation of patient and practitioner views about barriers to self-management in people with multimorbidity. BMC Health Serv Res. 2014;14:536.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55:68–78.CrossRefPubMedGoogle Scholar
  62. 62.
    Patel M, Perrin K, Pritchard A, Williams M, Wijesinghe M, Weatherall M, et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology. 2013;18:546–52.CrossRefPubMedGoogle Scholar
  63. 63.
    Chan AH, Reddel HK, Apter A, Eakin M, Riekert K, Foster JM. Adherence monitoring and e-health: how clinicians and researchers can use technology to promote inhaler adherence for asthma. J Allergy Clin Immunol Pract. 2013;1:446–54.CrossRefPubMedGoogle Scholar
  64. 64.
    Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19:696–704.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Pritchard JN, Nicholls C. Emerging technologies for electronic monitoring of adherence, inhaler competence, and true adherence. J Aerosol Med Pulm Durg Deliv. 2015;28:69–81.CrossRefGoogle Scholar
  66. 66.
    Williamson SS, Gorman PN, Jimison HB. A mobile/web app for long distance caregivers of older adults: functional requirements and design implications from a user centered design process. AMIA Annu Symp Proc. 2014;2014:1960–9.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Boulos MN, Brewer AC, Karinmkhani C, Buller DB, Dellavalle RP. Mobile medical and health apps: state of the art, concerns, regulatory control and certification. Online J Public Health Inform. 2014;5:229.PubMedPubMedCentralGoogle Scholar
  68. 68.
    Wieshammer S, Dreyhaupt J. Dry powder inhalers: which factors determine the frequency of handling errors? Respiration. 2008;75:18–25.CrossRefPubMedGoogle Scholar
  69. 69.
    Barros G, Pegram A, Borries A. Inhaler device selection: special considerations in elderly patients with chronic obstructive pulmonary disease. Am J Health-Syst Pharm. 2011;68:1221–32.CrossRefGoogle Scholar
  70. 70.
    Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med. 2012;186:240–5.CrossRefPubMedGoogle Scholar
  71. 71.
    Reijnders J, van Heugten C, van Boxtel M. Cognitive interventions in healthy older adults and people with mild cognitive impairment: a systematic review. Ageing Res Rev. 2013;12:263–75.CrossRefPubMedGoogle Scholar
  72. 72.
    Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913–22.CrossRefPubMedGoogle Scholar
  73. 73.
    Villeneuve S, Pepin V, Rahayel S, Bertrand JA, de Lorimier M, Rizk A, et al. Mild cognitive impairment in moderate to severe COPD: a preliminary study. Chest. 2012;142:1516–23.CrossRefPubMedGoogle Scholar
  74. 74.
    Armitage JM, Williams SJ. Inhaler technique in the elderly. Age Ageing. 1988;17:275–8.CrossRefPubMedGoogle Scholar
  75. 75.
    Gray SL, Williams DM, Pulliam CC, Sirgo MA, Bishop AL, Donohue JF. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med. 1996;156:984–8.CrossRefPubMedGoogle Scholar
  76. 76.
    Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J. Guidance on handheld inhalers in asthma and COPD guidelines. Respir Med. 2014;108:694–700.CrossRefPubMedGoogle Scholar
  77. 77.
    Lavorini F. Inhaled drug delivery in the hands of the patient. J Aerosol Med Pulm Drug Deliv. 2014;27:414–8.CrossRefPubMedGoogle Scholar
  78. 78.
    Dekhuijzen PN, Vincken W, Virchow JC, Roche N, Agusti A, Lavorini F, et al. Prescription of inhalers in asthma and COPD: towards a rational, rapid and effective approach. Respir Med. 2013;107:1817–21.CrossRefPubMedGoogle Scholar
  79. 79.
    Vinken W, Dekhuijzen R, Barnes PJ, on behalf of the ADMIT Group. The ADMIT series—issues in inhalation therapy. How to choose inhaler devices for the treatment of COPD. Prim Care Respir J. 2010;19:10–20.CrossRefGoogle Scholar
  80. 80.
    Lavorini F, Fontana GA. Inhaler technique and patient’s preference for dry powder inhaler devices. Expert Opin Drug Deliv. 2014;11:1–3.CrossRefPubMedGoogle Scholar
  81. 81.
    Price D, Harrow B, Small M, Pike J, Higgins V. Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians. World Allergy Organ J. 2015;8:26.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med. 2000;94:496–500.CrossRefPubMedGoogle Scholar
  83. 83.
    Molimard M, Colthorpe P. Inhaler devices for chronic obstructive pulmonary disease: insights from patients and healthcare practitioners. J Aerosol Med Pulm Drug Deliv. 2015;28:219–28.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    Chapman KR, Love L, Brubaker H. A comparison of breath-actuated and conventional metered-dose inhaler inhalation techniques in elderly subjects. Chest. 1993;104:1332–7.CrossRefPubMedGoogle Scholar
  85. 85.
    Ho SF, Ms OM, Steward JA, Breay P, Burr ML. Inhaler technique in older people in the community. Age Ageing. 2004;33:185–8.CrossRefPubMedGoogle Scholar
  86. 86.
    Poole PJ, Saini R, Brodie SM, Black PN. Comparison of the effects of nebulized and inhaled salbutamol on breathlessness in severe COPD. Respir Med. 2005;99:372–6.CrossRefPubMedGoogle Scholar
  87. 87.
    Berry RB, Shinto RA, Wong FH, Despars JA, Light RW. Nebulizer vs spacer for bronchodilator delivery in patients hospitalized for acute exacerbations of COPD. Chest. 1989;96:1241–6.CrossRefPubMedGoogle Scholar
  88. 88.
    van der Palen J, Klein JJ, Kerkhoff AH, van Herwaarden CL. Evaluation of the effectiveness of 4 different inhalers in patients with COPD. Thorax. 1995;50:1183–7.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Jones V, Fernandez C, Diggory P. A comparison of large volume spacer, breath-activated and dry powder inhalers in older people. Age Ageing. 1999;28:481–4.CrossRefPubMedGoogle Scholar
  90. 90.
    Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care. 2005;50:1360–74.PubMedGoogle Scholar
  91. 91.
    Sestini P, Cappiello V, Aliani M, Martucci P, Sena A, Vaghi A, Associazione Italiana Pneumologi Ospedalieri Educational Group, et al. Prescription bias and factors associated with improper use of inhalers. J Aerosol Med. 2006;19:127–36.CrossRefPubMedGoogle Scholar
  92. 92.
    Göriş S, Taşci S, Elmali F. The effects of training on inhaler technique and quality of life in patients with COPD. J Aerosol Med Pulm Drug Deliv. 2013;26:336–44.CrossRefPubMedGoogle Scholar
  93. 93.
    Jolly GP, Mohan A, Guleria R, Poulose R, George J. Evaluation of metered dose inhaler use technique and response to educational training. Indian J Chest Dis Allied Sci. 2015;57:17–20.PubMedGoogle Scholar
  94. 94.
    Self TH, Arnold LB, Czosnowski LM, Swanson JM, Swanson H. Inadequate skill of healthcare professionals in using asthma inhalation devices. J Asthma. 2007;44:593–8.CrossRefPubMedGoogle Scholar
  95. 95.
    Casset A, Meunier-Spitz M, Rebotier P, Lefèvre H, Barth C, Heitz C, et al. Asthma management and inhalation techniques among community pharmacists in 2009: a comparison with the 1999 survey. J Asthma. 2014;51:964–73.CrossRefPubMedGoogle Scholar
  96. 96.
    Gemicioglu B, Borekci S, Can G. Investigation of knowledge of asthma and inhaler devices in pharmacy workers. J Asthma. 2014;51:982–8.CrossRefPubMedGoogle Scholar
  97. 97.
    Basheti IA, Qunaibi EA, Hamadi SA, Reddel HK. Inhaler technique training and health-care professionals: effective long-term solution for a current problem. Respir Care. 2014;59:1716–25.CrossRefPubMedGoogle Scholar
  98. 98.
    De Tratto K, Gomez C, Ryan CJ, Bracken N, Steffen A, Corbridge SJ. Nurses’ knowledge of inhaler technique in the inpatient hospital setting. Clin Nurse Spec. 2014;28:156–60.CrossRefPubMedGoogle Scholar
  99. 99.
    Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel’s knowledge of and ability to use inhaling devices—metered-dose inhalers, spacing chambers, and breath-actuated powder inhalers. Chest. 1994;105:111–6.CrossRefPubMedGoogle Scholar
  100. 100.
    Kim SH, Kwak HJ, Kim TB, Chang YS, Jeong JW, Kim CW, et al. Inappropriate techniques used by internal medicine residents with three kinds of inhalers (a metered dose inhaler, Diskus, and Turbuhaler): changes after a single teaching session. J Asthma. 2009;46:944–95.CrossRefPubMedGoogle Scholar
  101. 101.
    Leung J, Bhutani M, Leigh R, Pelletier D, Good C, Sin DD. Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma. Can Respir J. 2015;22:266–70.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  • Federico Lavorini
    • 1
  • Claudia Mannini
    • 1
  • Elisa Chellini
    • 1
  • Giovanni A. Fontana
    • 1
  1. 1.Department of Experimental and Clinical MedicineCareggi University HospitalFlorenceItaly

Personalised recommendations